Browse By Tags
All tags
Spring 2021
Practice Notes
Employee Benefits & Executive Compensation
FEATURESPECIAL
Life Sciences
Alainna Nichols
over 4 years ago
The Journal
PA
Avoiding False Claims Act Risks Relating to Federal Funding for Coronavirus (COVID-19) Relief
By: Matthew D. Jenkins , Hunton Andrews Kurth LLP This article provides an overview of compliance obligations and federal False Claims Act (FCA) risks to healthcare and life sciences companies arising out of three funding streams made available in response...
Alainna Nichols
over 4 years ago
The Journal
PA
DOL’S Final ERISA Proxy Voting Rule Largely Changed to Principles-Based Approach
By: Michael B. Richman , Julie K. Stapel , Craig A. Bitman , Lindsay B. Jackson , Daniel R. Kleinman , and Natalie R. Wengroff , Morgan, Lewis & Bockius LLP The U.S. Department of Labor (DOL) has released its final rule on the application of the...